WHEAT RIDGE, Colo. -- GeneThera Inc. has chosen the Tecan Freedom EVO(TM) system to aid in its test process for mad cow disease as well as other veterinary diseases.

The system will be installed in its Wheat Ridge, Colo., lab as well as in each testing facility the GenaThera opens in the future.

"The Tecan product is a superior system that will allow GeneThera to streamline our live animal blood testing and allow us to automatically run our tests with 100-percent accuracy," said Tony Milici, CEO. "We have standardized on the Freedom EVO(R) system which will allow for each lab to come on-line much sooner without the delay of training personnel on new products and procedures. All training will be done in our Wheat Ridge facility prior to sending each new system to our international labs."

Jeff Aufmann, Tecan's vice president of sales, said, "We are proud to have GeneThera select Tecan as their equipment and testing partner. To have the opportunity to advance GeneThera's live animal testing assay with our product and to work with Dr. Milici throughout GeneThera's labs is of great importance to our company."

GeneThera Inc. is a molecular biotechnology company located in Wheat Ridge, Colo. The company provides genetic diagnostic solutions for the veterinary and agricultural industries, with future plans to include the healthcare industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA(TM), a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies.

The GEA is designed for a host of individual diseases, the current priority being Mad Cow disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johnne's Disease, diseases affecting cattle worldwide.

Tecan specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics and diagnostics. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries.

SOURCE: GeneThera Inc. via Business Wire.